SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Pharmacia Corp. a future biotech powerhouse? -- Ignore unavailable to you. Want to Upgrade?


To: Jack Hartmann who wrote (19)7/25/2000 11:21:50 AM
From: Jack Hartmann  Read Replies (1) | Respond to of 35
 
Pharmacia (PHA) 56 9/16 +3 9/16: Reports Q2 earnings of $0.47 a share, in line with the First Call consensus of $0.47, vs year-ago earnings of $0.80; revenues rose 15.4% to $5.03 bln from a year-ago of $4.36 bln;
*********
$19M in Zyvox sales. The new anti-botic is the drug to watch.
Jack